Harvard Business Review November 14, 2016
Alexander L. Fogel and Joseph C. Kvedar

Businesses that are serious about reducing health care costs — and improving the health and well-being of their employees — should take a serious look at digital therapeutics, which have the potential to provide effective, low-cost ways to prevent and treat chronic diseases and their consequences. Digital therapeutics are technology-based solutions that have a clinical impact on disease comparable to that of a drug. They primarily use consumer-grade technology such as mobile devices, wearable sensors, big data analytics, and behavioral science and can be delivered through web browsers, apps, or in conjunction with medical devices. They can also be deployed in real time and at scale, which is critical for intervention in chronic diseases.

These broad applications now include artificial-intelligence-driven...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Analytics, Apps, Big Data, Employer, Health IT, Health System / Hospital, Medicaid, Medicare, Medicare Advantage, mHealth, Patient / Consumer, Payer, Physician, Population Health Mgmt, Pricing / Spending, Primary care, Provider, RCM (Revenue Cycle Mgmt), Self-insured, Telehealth, Wearables
Related Articles:
Experts highlight urgent need for US physician strike regulations
China marks muted 5th anniversary of first COVID death
AI tool assists doctors in sharing lab results
New York hospitals complete merger and unveil new name
Student-Run Clinics Expand Access to Dermatology Care

Share This Article